Nightmare Bacteria EXPLODE—Hospitals On Edge

Green bacteria among intestine lining cells, microscopic view.

America’s hospitals are facing a new crisis as drug-resistant ‘nightmare bacteria’ surge 70%, threatening routine medical care and exposing the flaws of past federal oversight.

Story Snapshot

‘Nightmare bacteria’ infections climbed nearly 70% nationwide from 2019 to 2023.
Cases driven by the NDM gene jumped 460%, outpacing all previous estimates.
CDC data misses major states, suggesting the real numbers may be far higher.
Only two expensive antibiotics remain effective, raising costs and risks for patients.

Sharp Rise in Drug-Resistant Infections Threatens U.S. Healthcare

Between 2019 and 2023, reported cases of highly resistant bacteria—dubbed ‘nightmare bacteria’—have soared by nearly 70% across the United States. The Centers for Disease Control and Prevention (CDC) confirmed that strains carrying the NDM gene, which renders most antibiotics useless, account for much of this increase. With over 4,300 carbapenem-resistant infections and 1,831 NDM cases recorded in 2023 alone, experts warn that hospital stays, surgical procedures, and even routine treatments are now at heightened risk. CDC surveillance currently covers just 29 states, omitting several major population centers, which means the true scope of the crisis may be far worse.

The COVID-19 pandemic exacerbated the problem as hospitals relied heavily on antibiotics, fueling resistance and allowing these superbugs to gain ground. Data shows NDM infections exploded by 460% over the last four years. Many U.S. hospitals still lack advanced testing needed to detect and contain these dangerous strains, leaving communities vulnerable. The CDC’s September 2025 report in the Annals of Internal Medicine highlights not only the dramatic increase but also the grave public health risks, especially for those with chronic illnesses or weakened immune systems.

Limited Treatment Options and Surging Costs Endanger Patients

As nightmare bacteria proliferate, frontline doctors and patients face limited treatment choices. Only two available antibiotics—both intravenous and prohibitively expensive—show any effectiveness, meaning standard infections could soon become untreatable. Hospitalizations and medical costs are rising as doctors struggle to manage cases. Elderly Americans, those with chronic conditions, and anyone needing surgeries are at particular risk. The CDC and leading infectious disease experts warn that without immediate action on detection, stewardship, and drug development, routine medical care could be fundamentally undermined.

Healthcare workers exposed to resistant strains face increased risks, and community transmission is feared due to undetected carriers. The incomplete CDC surveillance further undercounts the true threat, as California, Florida, New York, and Texas are not included in the latest data. Public confidence in medical care could erode if the crisis deepens and effective solutions are not implemented quickly.

Pandemic-Era Policies and Regulatory Gaps Fuel Resistance

The surge in nightmare bacteria cases reflects deeper issues in federal oversight and pandemic-era policy. The COVID-19 response, marked by widespread antibiotic use and lack of robust surveillance, left the door open for resistance to grow unchecked. Many hospitals still lack the resources and technology needed for advanced testing, while incomplete state participation in CDC monitoring means many cases go undetected. Experts point to the urgent need for improved stewardship, stronger infection control, and incentives for developing new antibiotics—areas neglected amid the focus on globalist agendas and government overreach in previous years.

‘Nightmare bacteria’ infections are up 70% — what to know about this ‘triple threat’ to your health https://t.co/32k4zYNBPr pic.twitter.com/2eRRJKMUGk

— New York Post (@nypost) September 29, 2025

Industry leaders such as Dr. David Weiss of Emory and Dr. Maroya Walters of the CDC have called the rise of NDM gene-driven infections a “grave danger,” with the real possibility that routine illnesses may soon become untreatable. Their consensus highlights the failures of past regulatory approaches and the necessity of real reform. Without decisive action, Americans could face higher mortality, skyrocketing costs, and the loss of confidence in our healthcare system—an outcome that demands urgent attention from policymakers committed to protecting individual liberty, family values, and the integrity of our nation’s medical care.